Canada Pension Plan Investment Board Ironwood Pharmaceuticals Inc Transaction History

Canada Pension Plan Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$11.05 - $12.72 $981,240 - $1.13 Million	88,800 New	88,800 $1.02 Million
Q1 2022 May 13, 2022	SELL	$10.61 - $12.88 $3.14 Million - $3.82 Million	-296,370 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $3.22 Million - $4.13 Million	296,370 New	296,370 $3.46 Million
Q3 2020 Nov 12, 2020	SELL	$8.99 - $10.74 $3.06 Million - $3.65 Million	-339,907 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $3.11 Million - $4.07 Million	339,907 New	339,907 $3.51 Million
Q1 2020 May 13, 2020	SELL	$8.58 - $14.01 $457,374 - $746,831	-53,307 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.22 - $14.0 $88,833 - $151,298	10,807 Added 25.43%	53,307 $710,000
Q3 2019 Nov 12, 2019	SELL	$8.59 - $10.96 $756,779 - $965,576	-88,100 Reduced 67.46%	42,500 $365,000
Q2 2019 Aug 12, 2019	SELL	$9.8 - $12.89 $3.69 Million - $4.86 Million	-377,000 Reduced 74.27%	130,600 $1.43 Million
Q1 2019 May 15, 2019	BUY	$8.27 - $12.73 $913,008 - $1.41 Million	110,400 Added 27.79%	507,600 $6.87 Million
Q4 2018 Feb 06, 2019	BUY	$7.8 - $16.13 $3.1 Million - $6.41 Million	397,200 New	397,200 $4.12 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.